TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT00763828

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Life Recovery Systems ThermoSuit
Description: Hypothermia induction (cooling to 32 to 34 degrees C core temperature) using the Life Recovery Systems ThermoSuit System (a device which cools patients using direct skin contact with cold water) followed by PCI (percutaneous coronary intervention) and maintenance of hypothermia for 3 hours following PCI.
Study: NCT04835129

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab (for run-in portion)
Description: 10 mg/kg IV on days 2, 8, 15, 22 of cycle 2 and days 1 and 15 of subsequent cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Isatuximab (for expansion)
Description: 10 mg/kg IV on days 2, 8, 15, 22 of cycle 1 and days 1 and 15 of subsequent cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: 4 mg PO days 1-21 of each cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: 4 mg PO days 1-21 of each cycle.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elotuzumab
Description: 10 mg/kg on days 1, 8, 15, 22 of cycles 1 and 2; 20 mg/kg on day 1 of subsequent cycles.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elotuzumab
Description: 10 mg/kg on days 1, 8, 15, 22 of cycles 1 and 2; 20 mg/kg on day 1 of subsequent cycles.
Study: NCT04689269

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The simulated easy airway
Description: A high-fidelity simulator (Airway Management Trainer, model AA-3100, Laerdal Medical Ltd., Orpington, England, UK) will be equipped to create an easy airway situation by adjusting the manikin until it becomes in a neutral position

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The simulated easy airway
Description: A high-fidelity simulator (Airway Management Trainer, model AA-3100, Laerdal Medical Ltd., Orpington, England, UK) will be equipped to create an easy airway situation by adjusting the manikin until it becomes in a neutral position

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The simulated difficult airway
Description: A high-fidelity simulator (Airway Management Trainer, model AA-3100, Laerdal Medical Ltd., Orpington, England, UK) will be equipped to create a difficult airway scenario will be established by placing the occiput on an Oasis Elite™ Prone Head Rest, Adult (140 mm in height) (Covidien, Mansfield, MA, USA), and inhibiting head and neck movement by securing the head with an adhesive tape, simulating the effect produced by a cervical-collar.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The simulated difficult airway
Description: A high-fidelity simulator (Airway Management Trainer, model AA-3100, Laerdal Medical Ltd., Orpington, England, UK) will be equipped to create a difficult airway scenario will be established by placing the occiput on an Oasis Elite™ Prone Head Rest, Adult (140 mm in height) (Covidien, Mansfield, MA, USA), and inhibiting head and neck movement by securing the head with an adhesive tape, simulating the effect produced by a cervical-collar.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: King Vision Laryngoscope
Description: Using a King Vision Laryngoscope for placement of the DLT

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: King Vision Laryngoscope
Description: Using a King Vision Laryngoscope for placement of the DLT

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MacGrath Laryngoscope
Description: Using a MacGrath Laryngoscope for placement of the DLT

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MacGrath Laryngoscope
Description: Using a MacGrath Laryngoscope for placement of the DLT
Study: NCT06540027

Intervention type: PROCEDURE
Intervention: rectal cacer surgery
Description: minimally invasive surgery

Intervention type: PROCEDURE
Intervention: rectal cacer surgery
Description: minimally invasive surgery

Intervention type: PROCEDURE
Intervention: rectal cacer surgery
Description: minimally invasive surgery
Study: NCT05514418

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intensive Adherence Counselling (IAC)
Description: Intensive adherence counselling is offered to people living with HIV (PLHIV) having a non-suppressed viral load (VL) result ( a VL of 1,000 copies/ml or more) and this is given once every month for three months. In our study, we are going to give IAC to PLHIV with low-level viraemia (having a VL of 50 copies/ml but less than 1,000 copies/ml) and determine its effectiveness in causing a non-detectable VL (less than 50 copies/ml), which is desirable for PLHIV on ART.
Study: NCT05763693

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin at Baseline
Description: this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at baseline

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin at Baseline
Description: this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at baseline

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin at Day 21
Description: this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at the day 21 visit

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Azithromycin at Day 21
Description: this group will be randomized to receive a single oral dose of azithromycin (20mg/kg) at the day 21 visit

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo at Baseline
Description: this group will be randomized to receive Placebo at baseline

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo at Baseline
Description: this group will be randomized to receive Placebo at baseline

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo at Day 21
Description: This group will be randomized to receive Placebo at the day 21 visit

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo at Day 21
Description: This group will be randomized to receive Placebo at the day 21 visit
Study: NCT03959631

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Virtual Communities of practice
Description: based on a web 2.0 platform in which there is interaction with other patients and with a multidisciplinary team of professionals. The intervention will be co-designed with a group of patients and a group of primary and specialized care professionals.
Study: NCT05791955

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminder of preventive care measures
Description: The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures.~The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.
Study: NCT04835129

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: 40 mg (20 mg if \>75 years) PO or IV on days 1, 8,15 and 22 of each cycle.
Study: NCT05791955

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminder of preventive care measures
Description: The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures.~The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Reminder of preventive care measures
Description: The investigators will send randomized participants an SMS reminder encouraging them to click the provided link and close their outstanding, overdue preventive care measures.~The provided link will take them to their MyChart login page; after logging in, they would see their personalized My Action Plan Letter detailing their personalized, overdue preventive care measures.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Acknowledgement of personal responsibility
Description: The message will contain a request for the participant to take personal responsibility for their health by either clicking on the link to make an appointment or replying noted to the text message.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Planning prompt
Description: The message will prompt people to either click on the link to make an appointment now or text back when they plan to close their health gap
Study: NCT05116215

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrogen
Description: Hydrogen supplement

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrogen
Description: Hydrogen supplement

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydrogen
Description: Hydrogen supplement
Study: NCT05600803

Intervention type: PROCEDURE
Intervention: Single-operator cholangioscopy
Description: SpyGlass (Boston Scientific Co, Marlborough, USA) which enabled the direct visualization of the pancreaticobiliary system for the evaluation of intraductal lesions
Study: NCT05086380

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction therapy
Description: MBSR Therapy is a structured 8-week program that employs mindfulness meditation to alleviate suffering associated with physical, psychosomatic and psychiatric disorders. The program is based upon a systematic procedure to develop enhanced awareness of moment-to-moment experience of perceptible mental processes.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Inhibitory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using cTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Inhibitory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using cTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Inhibitory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using cTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Inhibitory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using cTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: Participants will learn about the symptoms and how to cope with the symptoms

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TMS sham
Description: The device will be used to neuromodulate the right TPJ of participants' brain using transcranial magnetic stimulation over the vertex

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS sham
Description: The device will be used to neuromodulate the right TPJ of participants' brain using transcranial magnetic stimulation over the vertex
Study: NCT05167929

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-determination Enhancement Group
Description: The self-determination enhancement group - Each group has eight participants. There will be 10 sessions per group and each session will last 1.5 hours.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-determination Enhancement Plus Group
Description: The self-determination enhancement PLUS group - Each group has eight participants and their caregivers. There will be 10 sessions per group and each session will last 1.5 hours. Meanwhile, their caregivers will attend four sessions separately and each session will last 1.5 hours.
Study: NCT05086380

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TMS sham
Description: The device will be used to neuromodulate the right TPJ of participants' brain using transcranial magnetic stimulation over the vertex

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: TMS sham
Description: The device will be used to neuromodulate the right TPJ of participants' brain using transcranial magnetic stimulation over the vertex

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excitatory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using iTBS stimulation protocol for transcranial magnetic stimulation
Study: NCT05167929

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Leisure activity group
Description: Leisure activity group - Leisure activity group is the comparison group. Each group will consist of eight adults with mild intellectual disability. There will be 10 sessions for the group and each session will last for 1.5 hours.
Study: NCT05086380

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Excitatory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using iTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excitatory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using iTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excitatory TMS
Description: The device will be used to neuromodulate the right TPJ of participants' brain using iTBS stimulation protocol for transcranial magnetic stimulation

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: The device will be used to manipulate the perception of symptoms of patients while they are playing a game in virtual/augmented reality.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Reality
Description: The device will be used to manipulate the perception of symptoms of patients while they are playing a game in virtual/augmented reality.
Study: NCT04937478

Intervention type: OTHER
Intervention: Observation
Description: Only observational study, no intervention.
Study: NCT04823130

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dupilumab (SAR231893)
Description: Pharmaceutical form: solution for injection Route of administration: subcutaneous
Study: NCT05389709

Intervention type: DRUG
Intervention: Iberogast (STW5-II, BAY98-7410)
Description: Survey without any intervention assigned in the study.
Study: NCT06553144

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control
Description: Canals were irrigated with only10 mL of 5% NaOCl

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: methylene blue
Description: 0.1 mg/mL methylene blue solition delivered into the canal and irradiated with a 100mW diode laser at a wavelength of 660 nm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: erythrosine b
Description: 0.3 mg/mL eryrhtosine b solition delivered into the canal and irradiated with a 100mW diode laser at a wavelength of 660 nm

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: curcumin
Description: 5.0 mg/mL curcumin solition delivered into the canal and irradiated with a 200mW diode laser at a wavelength of 450 nm
Study: NCT06492785

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: High Hyaluronic Acid concentrations (0.5 mg/ml)
Description: Hyaluronic Acid(EmbryoGlue®)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Low Hyaluronic Acid concentrations (0.125 mg/ml)
Description: Hyaluronic Acid (G2 medium)
Study: NCT06381258

Intervention type: PROCEDURE
Intervention: Ultrasound
Description: Fetal echocardiography using ultrasound device

Intervention type: PROCEDURE
Intervention: Ultrasound
Description: Fetal echocardiography using ultrasound device
Study: NCT05836818

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Question (Q)
Description: Flu vaccine acceptance question: a question asked of participants about their willingness to accept a flu vaccine

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Question (Q)
Description: Flu vaccine acceptance question: a question asked of participants about their willingness to accept a flu vaccine
Study: NCT05332054

Intervention type: BIOLOGICAL
Intervention: Allogeneic CAR-T therapy
Description: N/A this is an observational study
Study: NCT06449755

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Radiologic examination
Description: Posoperative first week, month and third month On the x-ray of Hand AP view: metacarpal shortening On the x-ray of Hand 30 degree pronation view: dorsal angulation

Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Radiologic examination
Description: Posoperative first week, month and third month On the x-ray of Hand AP view: metacarpal shortening On the x-ray of Hand 30 degree pronation view: dorsal angulation

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Grip Strength
Description: Postoperative first month and third month grip streng compare with Cambry hand dinamometer.

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Grip Strength
Description: Postoperative first month and third month grip streng compare with Cambry hand dinamometer.
Study: NCT05086380

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Neurofeedback
Description: Neurofeedback training will be applied in patients while laying in an MRI scanner. Patients will play a game, which targets the sense of agency, and will receive a real-time feedback about their performance and brain activity. They will learn to self-regulate their performance on the game in order to increase brain activity relevant for the sense of agency.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: Neurofeedback training will be applied in patients while laying in an MRI scanner. Patients will play a game, which targets the sense of agency, and will receive a real-time feedback about their performance and brain activity. They will learn to self-regulate their performance on the game in order to increase brain activity relevant for the sense of agency.
Study: NCT05408780

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AC-OLE-01-VA
Description: formulation of tricaprilin or matching placebo

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AC-OLE-01-VA
Description: formulation of tricaprilin or matching placebo
Study: NCT05086926

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Exercises and CSI
Description: Corticosteroid injection:~The project manager will give the participants one injection with cortisone and lidocaine in the lateral hip at baseline. The procedure will be performed aseptically.~Home exercise program:~The exercise programis based on previous literature and expert opinions that has been synthesized in a Delphi study conducted by our research group. The exercise program consists of three body weighted strength exercises, that are to be performed every second day for a period of 8 weeks. Exercise instructions will be available as a handout and online with video instructions. The corticosteroid injection usually causes a flare-up in pain with a duration of up to 48 hours. Participants will be instructed to begin the exercises as soon as possible after this flare-up has settled.
Study: NCT05836818

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Messaging (M)
Description: Flu vaccine educational materials -videos and flyers containing flu vaccine educational information
Study: NCT05736588

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Elimisha HPV
Description: Elimisha HPV is a multi-level stigma-responsive cervical cancer prevention service delivery model that incorporates stigma-responsive education, peer navigation and a patient-centered delivery strategy, addressing drivers while mitigating harms from stigma.
Study: NCT06268106

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Graphic novel visualization
Description: Patients in interventional group do receive and visualize graphic novel, which is more informative than standard informed consent.
Study: NCT05707260

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: CKD SMS
Description: The intervention begins with a face-to-face or digitally assisted session, entry into improving the knowledge and self-management of CKD through, using the four sources of manipulation of self-efficacy (achievement of performance, indirect experience, verbal persuasion, and self-evaluation). In this session, participants will be asked to identify their problems related to CKD and establish, based on these two goals, that they are real and achievable according to their priorities. These goals will be recorded in the monitoring format and will be monitored in the telephone or WhatsApp follow-ups. This using the performance achievement manipulation source, said session lasts 60 minutes, as does the final session at week 16.
Study: NCT05140785

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Advanced MRI sequences
Description: Advanced MRI sequences which look to a) determine structure of a primary brain tumour and b) metabolism within a primary brain tumour
Study: NCT05327257

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS rTMS
Description: Repetitive transcranial magnetic stimulation (rTMS) intermittent Theta Burst Stimulation (iTBS)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS rTMS
Description: Repetitive transcranial magnetic stimulation (rTMS) intermittent Theta Burst Stimulation (iTBS)

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: iTBS rTMS
Description: Repetitive transcranial magnetic stimulation (rTMS) intermittent Theta Burst Stimulation (iTBS)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS rTMS
Description: Repetitive transcranial magnetic stimulation (rTMS) intermittent Theta Burst Stimulation (iTBS)

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: iTBS rTMS
Description: Repetitive transcranial magnetic stimulation (rTMS) intermittent Theta Burst Stimulation (iTBS)
Study: NCT04932993

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Writing down goals
Description: Patient will write their health goals down before the visit.
Study: NCT06277596

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Exercise
Description: Clinical Pilates exercises (basic and advanced stabilization exercises)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Clinical Pilates exercises (basic and advanced stabilization exercises)
Study: NCT06166485

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: take a bath
Description: The effects of two different bathtub bath methods on physiological parameters will be compared in babies divided into 2 different groups.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: take a bath
Description: The effects of two different bathtub bath methods on physiological parameters will be compared in babies divided into 2 different groups.